Search our Available Technologies
Biologics
Enhancing the effectiveness of cancer vaccines using linked heterologous or other foreign MHC II “helper” epitopes with or without the co-administration of agonistic anti-CD27 antibody
Value proposition Brain tumor is one of the most feared...
MORE >Sublingual immunization using supramolecular peptide-polymer conjugates
Value proposition Immunization prevents illness, disability and death from vaccine-preventable...
MORE >Enhanced delivery of drugs and other compounds to the brain and other tissues
The inventors have co-opted aspects of a natural phenomenon to...
MORE >Peptide reagents for Butyrylcholinesterase
Value proposition Cocaine intoxication and nerve agent toxicity are both...
MORE >Methods to increase influenza virus growth for vaccine production
Value Proposition Influenza A is a highly infectious viral disease...
MORE >Mechanism of complement activation by protein/heparin complexes
Value proposition Heparin-induced thrombocytopenia (HIT) is an immune mediated pro-thrombotic...
MORE >Vaccination against HER3, a mediator of resistance to ErbB targeted therapies
Value Proposition Cancer is considered one of the most widespread...
MORE >An adjuvant-free vaccine platform using self-assembling nanofibers
Value Proposition Vaccines have application for a wide range of...
MORE >Pharmacological approach to myelin repair
Value Proposition The white matter of the central nervous system...
MORE >Immunotherapy for Glioblastoma using Recombinant Antibodies
Value Proposition Glioblastoma multiforme (GBM) is the most common of...
MORE >